PD‐1/PD‐L1 Blockade Therapy in Advanced Non‐Small‐Cell Lung Cancer: Current Status and Future Directions

DOI: 10.1634/theoncologist.2019-IO-S1-s05

Keywords: Immune checkpoint inhibitors, PD‐1/PD‐L1, Non‐small‐cell lung cancer, Clinical trials, Combination therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text